New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

Today's Free Fly Stories
All of the free stories from today.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | all day >>
10:34 EDTAPRI, TKPYYApricus Biosciences reports Takeda accepts first shipment of Vitaros
Subscribe for More Information
10:31 EDTWILNWi-LAN acquires irrigation technology patents and revenue stream
Subscribe for More Information
10:30 EDTCrude Inventories for the week of April 11
Crude oil inventories 10.0M build vs. consensus of 1.75M build. Gasoline inventories 154K draw vs. consensus of 1.75M draw. Distillates 1.28M draw vs. consensus of flat.
10:28 EDTEGANeGain recent weakness seems unwarranted, says Ladenburg
Subscribe for More Information
10:28 EDTDNR, INFY, FSL, ENDHigh option volume stocks: DNR INFY FSL END SQQQ
Subscribe for More Information
10:27 EDTENDPEndo International says AMS unit received FDA warning letter
In a regulatory filing, Endo International disclosed that as previously reported in Endo Health Solutions's Form 10-K filed with the SEC on March 3, in February 2014, the United States FDA conducted an inspection of the Minnetonka, Minnesota facility of American Medical Systems, AMS, a subsidiary of Endo International. Following such inspection, the FDA issued three observations on a Form 483 Notice of Inspectional Observations dated February 24. These observations, previously self-identified by AMS, were being addressed through a corrective action plan which AMS originally expected to complete beyond 2015. On April 14, AMS received a Warning Letter from the FDA, dated April 10. The Warning Letter relates to the same matters as identified in the Form 483 Notice. Specifically, the Warning Letter discusses observations related to process validation, risk analysis and corrective and preventive action procedures. The letter states that the corrective actions which AMS reviewed with the FDA on March 20, 2014 appear to be adequate, but it goes on to state that many of the actions have not yet been completed and will need to be validated in a follow-up inspection. AMS has 15 days to respond to the Warning Letter. AMS expects only limited related impact to its business at this time. The Minnetonka, Minnesota facility will continue to manufacture and ship products while AMS works with the FDA.
10:27 EDTOPBOpusBank opens for trade at $30.00, IPO priced at $30.00
Subscribe for More Information
10:27 EDTGPNGlobal Payments management to meet with Oppenheimer
Subscribe for More Information
10:23 EDTOPBOpusBank IPO indicated to open $30.00
OpusBank (OPB) priced 5.126M shares at $30.00. JPMorgan and Credit Suisse acted as joint book running managers for the offering.
10:23 EDTHBANHuntington says credit quality continues to show 'steady' improvement
Subscribe for More Information
10:20 EDTToday's U.S. reports
Subscribe for More Information
10:18 EDTTASRTASER announces 3,279 in new TASER orders
TASER announced multiple orders of its TASER brand conducted electrical weapons and its next generation Smart Weapons. These orders either shipped in Q1 or are expected to ship in Q2.
10:16 EDTNFLXNetflix April weekly volatility elevated at 106 into Q1 and outlook
Subscribe for More Information
10:16 EDT$NYENYSE market internals summary
Subscribe for More Information
10:16 EDT$NSDNASDAQ market internals summary
Volume is very light for this time of day. Breadth is bullish across the board. Advancing Issues: 1483 / Declining Issues: 759 -- for a ratio of 2.0 to 1. Advancing Volume: 182,405,000 / Declining Volume: 91,323,000 -- for a ratio of 2.0 to 1. New 52-Week Highs: 18 / New 52-Week Lows: 9.
10:15 EDTFX Action: USD-CAD fell to 1.0960
Subscribe for More Information
10:13 EDTJCIJohnson Controls to host conference call
Subscribe for More Information
10:11 EDTBACBank of America falls after results, levels to watch
Shares are trading near the session low at $15.82 following earnings. At that price next support is at $15.18. Resistance is at $16.20.
10:09 EDTBCOBrink's downgraded to In-Line from Outperform at Imperial Capital
Subscribe for More Information
10:08 EDTUNH, AET, HUM, WLPUnitedHealth retreats after Citi cuts rating on shares
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | all day >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use